Monkeypox

Monkeypox Vaccine: Blue Water Biotech Touts Encouraging Preclinical Data From Monkeypox Vaccine Candidate
FDA Gives Emergency Use Nod To Roche's Monkeypox Test
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa
FDA Gives Emergency Use Nod To Roche's Monkeypox Test
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa
SIGA Updates on Progress Its Smallpox Drug Trials For Potential Use Against Monkeypox
SIGA Technologies Bags New DoD Contract For Monkeypox Treatment

Monkeypox Recent News

Chinese Health Official Says Don't Touch Foreigners To Avoid Monkeypox, Draws Flak On Social Media
A Chinese health official has advised residents to stay away from foreigners to prevent the spread of monkeypox infection after the country discovered its first known case of the virus.
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed
SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report
In an effort to prevent bioterrorism attacks, just in case, SIGA Technologies Inc (NASDAQ: SIGA) started working on the smallpox treatment, Tpoxx, after the 9/11 terrorist attack that shook the world. FDA approved Tpoxx for smallpox in 2018. 
Bavarian Nordic Making All Efforts To Stretch Capacity To Boost Monkeypox Vaccine Supplies
Bavarian Nordic A/S (OTC: BVNRY) said it was making "every effort" to meet the high demand for its monkeypox vaccine worldwide as it kept its business outlook for the year.
Researchers Behind COVID-19 RECOVERY Trial Launch New Monkeypox Treatment Trial
Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch
The only FDA-approved monkeypox vaccine from Bavarian Nordic A/S (OTC: BVNY) is in short supply.
Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test
Bavarian Nordic Recruits US Firm For Packaging Services For Its Monkeypox Vaccine
Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment
Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments.
A Biopharma Working On Malaria, Norovirus Vaccines Threw It's Hat In The Monkeypox Ring
Blue Water Vaccines Inc (NASDAQ: BWV) 
The Only Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand
Bavarian Nordic A/S (OTC: BVNKF), the only company with an approved vaccine for monkeypox, said it’s no longer sure it can meet demand as cases continue to rise worldwide, 
Rapid Test For Monkeypox? NY-Based Chembio Diagnostics Thinks They Can Pull It Off
Chembio Diagnostics Inc (NASDAQ: CEMI) is 
QIAGEN Launches Syndromic Test For QIAstat-Dx For Six Pathogens Similar To Monkeypox
EXCLUSIVE: Pasithea's Multiple Sclerosis Vaccine Candidate Shows Efficacy In Animal Studies, With Potential In Monkeypox
Pasithea Therapeutics Corp (NASDAQ: KTTA) has announced results from a preliminary preclinical proof of concept study of PAS002, its tolerizing vaccine for multiple sclerosis (MS).
Aethlon Medical To Start Lab Studies For Hemopurifier For Monkeypox
FDA Approves New Technique To Extend Supply Of Monkeypox Vaccine: Report
A plan to extend the limited supply of monkeypox vaccine in order to provide additional doses has been approved by the Food and Drug Administration.
Applied DNA Sciences Shares Triples After Monkeypox Diagnostic Test Update
Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak
The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as severe as the COVID-19 pandemic, but it has a number of health care and biotech stocks on the move.
Monkeypox A Nationally Notifiable Condition, CDC Poised To Announce: Report
Monkeypox Emergency Could Last Months, According To Experts
Bavarian Nordic's Monkeypox Vaccine Scores EU Approval As WHO Declares Global Health Emergency
6 Stocks To Watch As The World Health Organization Declares Monkeypox Outbreak A Global Emergency
The World Health Organization (WHO) on Saturday declared the monkeypox outbreak a global emergency, its highest level of alert. WHO Director-General Tedros Adhanom Ghebreyesus said more than 16,000 cases in more than 75 countries have now been reported around the world.